FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
January 11, 2026
January 11, 2026
WASHINGTON, Jan. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following news release:
* * *
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
*
The U.S. Food and Drug Administration today announced it is sharing information about the agency's flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene th . . .
* * *
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
*
The U.S. Food and Drug Administration today announced it is sharing information about the agency's flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene th . . .